About this blog: I have been investing for 25 years, professionally and personally. I look for stocks that have a high probability of compounding at 15% for at least 5 years with limited downside. I write these stocks up on my blog. You can find more about me, my philosophy, my mental models, and my portfolio structure on my site.
My last couple of notes (here and here) laid out how I reorganise Plan Value and how Brookfield has performed against its investor day promises over the years.
This got me thinking about how the BN discount and the valuations of the underlying assets have changed. I discuss each below but in short:
The market trusts BN’s Plan Value more than it did: the discount is narrowing.
If BN is cheap today - and I think it is - then it is because the underlying assets are cheaper, not because the discount is at record levels.
In the next few weeks I’ll publish deep dives into what Distributable Earnings is, and into BN’s two most important businesses: the asset manager BAM, and the all-consuming (literally) insurer BWS.
The discount to Plan Value
BN has reported Plan Value on a consistent basis since December 2022 when they spun out BAM. The graph below compares the share price to Plan Value on each balance sheet date, so it stops at 2a26 - it is not live. Interestingly the discount has trended down from the high 50% range to the high 30% range:
